Pharmaceuticals, Biotechnology and Life Sciences
-Boehringer Ingelheim is enrolling first patient to test nvestigational compound BI ENaC inhibitor delivered twice daily via the Respimat, a…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC) a clinical-stage biotechnology company pioneering a new and differentiated class of…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced the appointment of Kathryn…
TriPharm services creates Pharmaceutical manufacturing center to address Shortage of qualified parenteral manufacturing options in the U.S.
Amarna Therapeutics has raised €10 million in a round led by Swedish investor Flerie Invest AB with substantial contributions from…
Vaxess and GC Pharma will collaborate on Influenza vaccine smart release patch, in a deal which will give Vaxess exclusive…
Amphivena is set to move on with AMV564 in a Multi-Center Dose Finding Phase 1 Clinical Study in Patients with…
Enzyvant appoints former COO of Compass and Horizon Discovery as Chief Operating Officer, as the company nears first potential drug…
BOSTON–(BUSINESS WIRE)–Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into…
NOXXON said Wednesday it has enrolled the first patient in phase 1/2 trial in a therapy of increasing doses of…